Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | C-CAR039 |
| Trade Name | |
| Synonyms | JNJ-90014496|JNJ90014496|Prizloncabtagene Autoleucel|EXP-30|EXP039|JNJ-4496 |
| Drug Descriptions |
C-CAR039 is a chimeric antigen receptor T cell (CAR-T) therapy that targets CD19 and CD20, potentially resulting in a decrease in tumor cells (PMID: 39813680). |
| DrugClasses | CD19 Immune Cell Therapy 78 CD20 Immune Cell Therapy 17 |
| CAS Registry Number | NA |
| NCIT ID | C178452 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| C-CAR039 | C-CAR039 | 0 | 2 |